Antimicrobial Resistance Surveillance Market Size, Share, and Outlook, H2-2025 Report- By Solution (Diagnostic kits, Diagnostic systems, Surveillance software, Services), By Application (Clinical Diagnostics, Public Health Surveillance, Others), By End-Us
Description
Antimicrobial Resistance Surveillance Market Outlook
The global Antimicrobial Resistance Surveillance Market Size is valued at $6.4 Billion in 2025 and is forecast to reach $9.6 Billion in 2032 at a CAGR of 5.9%.
The Antimicrobial Resistance Surveillance Market continue to remain a steadily growing market and offers lucrative growth opportunities across the industry stakeholders from suppliers to distributors and end-use industries. This comprehensive market research report provides 12-year historic and forecast data on Antimicrobial Resistance Surveillance Market segments across 22 countries from 2021 to 2032. Key segments covered include By Solution (Diagnostic kits, Diagnostic systems, Surveillance software, Services), By Application (Clinical Diagnostics, Public Health Surveillance, Others), By End-User (Hospitals & Clinics, Research & Academic Institutes, Others), offering granular insights into performance drivers and emerging patterns. With over 70 tables and charts, the report provides actionable findings based on extensive data modeling and industry surveys.
Antimicrobial Resistance Surveillance Market Insights, 2025
The antimicrobial resistance (AMR) surveillance market is increasingly critical as global health authorities prioritize monitoring resistance trends to combat the rising threat of multidrug-resistant pathogens. Recent advancements include the deployment of next-generation sequencing (NGS) and whole-genome sequencing (WGS) technologies, enabling precise identification and tracking of resistance genes across clinical and environmental samples. Integration of digital platforms and AI-driven analytics improves real-time data collection, reporting, and decision-making capabilities. Collaborative networks between hospitals, public health agencies, and research institutions are expanding to create comprehensive surveillance ecosystems. Regulatory agencies worldwide are enforcing stricter guidelines for AMR data submission and transparency. The growing prevalence of resistant infections drives demand for standardized, high-throughput susceptibility testing tools and surveillance protocols. Emerging markets are enhancing infrastructure and laboratory capabilities to participate in global AMR initiatives. Increased funding and international collaborations are accelerating innovation and data sharing.
Five Trends Shaping the Global Antimicrobial Resistance Surveillance Market in 2025 and Beyond
The global Antimicrobial Resistance Surveillance Industry is undergoing a paradigm shift driven by regulatory changes, technological innovation, and sustainability imperatives. Amidst intense demand growth from diverse end-users, companies are focusing on new product launches to cater to individual applications. Companies are also emphasizing operational resilience and circular economy principles and are aligning strategies to secure long-term growth. The report identifies key structural changes, disruptive technologies, and evolving trade flows influencing competitiveness, helping stakeholders strengthen decision-making for both the short and long term.
What are the Biggest Opportunities for Growth in the Antimicrobial Resistance Surveillance Industry?
The Antimicrobial Resistance Surveillance Market sector has shown strong adaptability amid volatility in prices, supply chain disruptions, and geopolitical tensions. Moving forward, potential opportunities lie in niche products, aggressive distribution activities, and digital process optimization. With increasing demand from emerging markets, Antimicrobial Resistance Surveillance Market is positioned for growth through 2030 and beyond. This chapter provides a strategic perspective for businesses to identify revenue-generating avenues, mitigate risks, and adopt innovative pathways for expansion.
Antimicrobial Resistance Surveillance Market Segment Insights
The Antimicrobial Resistance Surveillance Industry offers diverse opportunities across product types, applications, and distribution channels. The analytical report provides detailed forecasts across diverse segments including By Solution (Diagnostic kits, Diagnostic systems, Surveillance software, Services), By Application (Clinical Diagnostics, Public Health Surveillance, Others), By End-User (Hospitals & Clinics, Research & Academic Institutes, Others). Insights cover the largest and fastest-growing product types, applications, and regions, highlighting drivers behind each segment. Market outlooks are provided for five regions—Asia Pacific, North America, Europe, South America, and Middle East & Africa—with country-level forecasts for 22 markets through 2032.
Antimicrobial Resistance Surveillance Industry Value Chain
The chapter identifies potential companies and their operations across the global Antimicrobial Resistance Surveillance Industry ecosystem. It assists decision-makers in evaluating global Antimicrobial Resistance Surveillance Market fundamentals, market dynamics, and disruptive trends across the value chain segments. According to the International Council of Chemical Associations (ICCA), chemicals underpin over 95% of manufactured products worldwide.
Scenario Analysis and Forecasts
Strategic planning in the Antimicrobial Resistance Surveillance Industry requires resilience to uncertain macroeconomic and regulatory conditions. To guide stakeholders, the report offers three scenario forecasts—low growth, reference case, and high growth—enabling companies to align strategies under different market conditions.
Asia Pacific Antimicrobial Resistance Surveillance Market Analysis – Hub of Industrial Transformation
Asia Pacific continues to be the largest and fastest-growing region for Antimicrobial Resistance Surveillance Market, underpinned by rapid industrialization, large-scale infrastructure development, and rising consumption across emerging economies. China, India, and Southeast Asia lead the demand surge, supported by investments in chemical parks, free trade agreements, and rising domestic manufacturing capacity. China remains the single largest producer and consumer of chemicals, accounting for over $1.5 trillion in chemical sales, followed by India, which is projected by the India Brand Equity Foundation (IBEF) to become a $300 billion chemicals market by 2025. Further, Japanese and South Korean markets remain stable with most companies focusing on new product launches and diversification of sales channels.
United States Antimicrobial Resistance Surveillance Market Insights – Innovation and Specialty Leadership
The American Chemistry Council (ACC) projects steady annual demand growth for specialty and performance chemicals, particularly in automotive, electronics, agriculture, and construction applications. The US continues to lead in specialty and high-value-added chemicals, with investments focused on R&D, advanced process technologies, and digital manufacturing. In addition, the Canadian and Mexican markets offer lucrative growth pockets for manufacturers and vendors. Focus on private-brand offerings and promotions, diversified sales channels, expansion into niche segments, adoption of advanced technologies, and sustainability are widely observed across the North American Antimicrobial Resistance Surveillance Market.
Europe Antimicrobial Resistance Surveillance Market Outlook 2025 – Regulatory and Innovation-Driven Growth
Europe is one of the largest markets for Antimicrobial Resistance Surveillance Market with demand from both Western Europe and Eastern European regions increasing over the medium to long-term future. The European chemical sector employs more than 1.2 million people directly and is highly influenced by the EU Green Deal, which aims for climate neutrality by 2050. With increasing adoption of advanced technologies, raw materials, and digital transformation, Europe remains a strategic hub for Antimicrobial Resistance Surveillance Industry competitiveness. The report analyses the key Antimicrobial Resistance Surveillance Market drivers and opportunities across Germany, France, the United Kingdom, Spain, Italy, Russia, and other Europe.
Latin American Antimicrobial Resistance Surveillance Market outlook rebounds in line with economic growth
Optimistic economic outlook across Brazil, Argentina, Chile, and other South and Central American countries presents strong opportunities for domestic and international Antimicrobial Resistance Surveillance Market companies. Increased consumer spending is estimated across markets over the next few quarters through 2026. Expanding trade partnerships, urbanization, and growing demand for specialty products underpin market prospects.
Middle East and Africa Antimicrobial Resistance Surveillance Markets- New Opportunities for Companies Harnessing Diversity
The Middle East remains a key hub for Antimicrobial Resistance Surveillance Market companies, with Saudi Arabia, UAE, and Qatar investing heavily in distribution networks. In addition, Africa presents strong growth potential in Nigeria, South Africa, and other emerging economies, with increasing demand for cost effective and accessible products. Investment strategies tailored to localized needs and sustainable growth will be crucial for success. In addition to Nigeria, Algeria, South Africa, and other markets, steady growth markets in Ethiopia, Rwanda, Ghana, Tanzania, the Democratic Republic of Congo, and others present significant prospects for companies.
Competitive Landscape – How Antimicrobial Resistance Surveillance Market Companies Outcompete in 2025
The ability to adapt to changing regulations, sustainability imperatives, and customer-specific innovations defines leadership in the Antimicrobial Resistance Surveillance Market. Companies are leveraging M&A activities, strategic joint ventures, and vertical integration to secure raw material access and strengthen downstream presence. The report profiles leading players, analyzing their 2024 revenues, market shares, R&D expenditures, and strategic directions. The report analyzes Abbott Laboratories, Accelerate Diagnostics Inc, Alifax S.r.l., Becton, Dickinson and Company, Bioanalyse GmbH, bioMérieux SA, Bio-Rad Laboratories Inc, BioSpace Inc, Bruker Corp, Danaher Corp, Danaher Corp, F. Hoffmann-La Roche Ltd, Liofilchem S.r.l., Lumed LLC, Luminex Corp, Merck KGaA, OpGen Inc, QIAGEN N.V., Thermo Fisher Scientific Inc, Wolters Kluwer N.V.. Each company is benchmarked through a detailed SWOT and financial analysis, providing clients with insights into competitive positioning and innovation leadership.
Antimicrobial Resistance Surveillance Market Scope
Leading Segments
By Solution
Diagnostic kits
Diagnostic systems
Surveillance software
Services
By Application
Clinical Diagnostics
Public Health Surveillance
Others
By End-User
Hospitals & Clinics
Research & Academic Institutes
Others
Leading Companies
Abbott Laboratories
Accelerate Diagnostics Inc
Alifax S.r.l.
Becton, Dickinson and Company
Bioanalyse GmbH
bioMérieux SA
Bio-Rad Laboratories Inc
BioSpace Inc
Bruker Corp
Danaher Corp
Danaher Corp
F. Hoffmann-La Roche Ltd
Liofilchem S.r.l.
Lumed LLC
Luminex Corp
Merck KGaA
OpGen Inc
QIAGEN N.V.
Thermo Fisher Scientific Inc
Wolters Kluwer N.V.
Geographies
North America- US, Canada, Mexico
Europe- Germany, France, UK, Spain, Italy, Nordics, BeNeLux, Others
Asia Pacific- China, India, Japan, South Korea, Australia, South East Asia, Others
Latin America- Brazil, Argentina, Others
Middle East and Africa- Saudi Arabia, UAE, Other Middle East, South Africa, Other Africa
Reasons to Buy the Report Make informed decisions with 12-year forecasts across 22 countries and multiple market segments. Evaluate regulatory impacts, sustainability trends, and disruptive technologies shaping the chemicals industry. Gain insights into the competitive landscape, including company profiles, financials, and strategic moves. Build an integrated understanding of the chemicals ecosystem across upstream, midstream, and downstream operations. Leverage insights on circular economy initiatives, digitalization, and carbon-neutral strategies driving the next decade. Assess risks and opportunities with scenario-based forecasts tailored to different growth conditions. Access the report in multiple formats (PDF, Excel, PPT) for easier integration into strategic planning.
The global Antimicrobial Resistance Surveillance Market Size is valued at $6.4 Billion in 2025 and is forecast to reach $9.6 Billion in 2032 at a CAGR of 5.9%.
The Antimicrobial Resistance Surveillance Market continue to remain a steadily growing market and offers lucrative growth opportunities across the industry stakeholders from suppliers to distributors and end-use industries. This comprehensive market research report provides 12-year historic and forecast data on Antimicrobial Resistance Surveillance Market segments across 22 countries from 2021 to 2032. Key segments covered include By Solution (Diagnostic kits, Diagnostic systems, Surveillance software, Services), By Application (Clinical Diagnostics, Public Health Surveillance, Others), By End-User (Hospitals & Clinics, Research & Academic Institutes, Others), offering granular insights into performance drivers and emerging patterns. With over 70 tables and charts, the report provides actionable findings based on extensive data modeling and industry surveys.
Antimicrobial Resistance Surveillance Market Insights, 2025
The antimicrobial resistance (AMR) surveillance market is increasingly critical as global health authorities prioritize monitoring resistance trends to combat the rising threat of multidrug-resistant pathogens. Recent advancements include the deployment of next-generation sequencing (NGS) and whole-genome sequencing (WGS) technologies, enabling precise identification and tracking of resistance genes across clinical and environmental samples. Integration of digital platforms and AI-driven analytics improves real-time data collection, reporting, and decision-making capabilities. Collaborative networks between hospitals, public health agencies, and research institutions are expanding to create comprehensive surveillance ecosystems. Regulatory agencies worldwide are enforcing stricter guidelines for AMR data submission and transparency. The growing prevalence of resistant infections drives demand for standardized, high-throughput susceptibility testing tools and surveillance protocols. Emerging markets are enhancing infrastructure and laboratory capabilities to participate in global AMR initiatives. Increased funding and international collaborations are accelerating innovation and data sharing.
Five Trends Shaping the Global Antimicrobial Resistance Surveillance Market in 2025 and Beyond
The global Antimicrobial Resistance Surveillance Industry is undergoing a paradigm shift driven by regulatory changes, technological innovation, and sustainability imperatives. Amidst intense demand growth from diverse end-users, companies are focusing on new product launches to cater to individual applications. Companies are also emphasizing operational resilience and circular economy principles and are aligning strategies to secure long-term growth. The report identifies key structural changes, disruptive technologies, and evolving trade flows influencing competitiveness, helping stakeholders strengthen decision-making for both the short and long term.
What are the Biggest Opportunities for Growth in the Antimicrobial Resistance Surveillance Industry?
The Antimicrobial Resistance Surveillance Market sector has shown strong adaptability amid volatility in prices, supply chain disruptions, and geopolitical tensions. Moving forward, potential opportunities lie in niche products, aggressive distribution activities, and digital process optimization. With increasing demand from emerging markets, Antimicrobial Resistance Surveillance Market is positioned for growth through 2030 and beyond. This chapter provides a strategic perspective for businesses to identify revenue-generating avenues, mitigate risks, and adopt innovative pathways for expansion.
Antimicrobial Resistance Surveillance Market Segment Insights
The Antimicrobial Resistance Surveillance Industry offers diverse opportunities across product types, applications, and distribution channels. The analytical report provides detailed forecasts across diverse segments including By Solution (Diagnostic kits, Diagnostic systems, Surveillance software, Services), By Application (Clinical Diagnostics, Public Health Surveillance, Others), By End-User (Hospitals & Clinics, Research & Academic Institutes, Others). Insights cover the largest and fastest-growing product types, applications, and regions, highlighting drivers behind each segment. Market outlooks are provided for five regions—Asia Pacific, North America, Europe, South America, and Middle East & Africa—with country-level forecasts for 22 markets through 2032.
Antimicrobial Resistance Surveillance Industry Value Chain
The chapter identifies potential companies and their operations across the global Antimicrobial Resistance Surveillance Industry ecosystem. It assists decision-makers in evaluating global Antimicrobial Resistance Surveillance Market fundamentals, market dynamics, and disruptive trends across the value chain segments. According to the International Council of Chemical Associations (ICCA), chemicals underpin over 95% of manufactured products worldwide.
Scenario Analysis and Forecasts
Strategic planning in the Antimicrobial Resistance Surveillance Industry requires resilience to uncertain macroeconomic and regulatory conditions. To guide stakeholders, the report offers three scenario forecasts—low growth, reference case, and high growth—enabling companies to align strategies under different market conditions.
Asia Pacific Antimicrobial Resistance Surveillance Market Analysis – Hub of Industrial Transformation
Asia Pacific continues to be the largest and fastest-growing region for Antimicrobial Resistance Surveillance Market, underpinned by rapid industrialization, large-scale infrastructure development, and rising consumption across emerging economies. China, India, and Southeast Asia lead the demand surge, supported by investments in chemical parks, free trade agreements, and rising domestic manufacturing capacity. China remains the single largest producer and consumer of chemicals, accounting for over $1.5 trillion in chemical sales, followed by India, which is projected by the India Brand Equity Foundation (IBEF) to become a $300 billion chemicals market by 2025. Further, Japanese and South Korean markets remain stable with most companies focusing on new product launches and diversification of sales channels.
United States Antimicrobial Resistance Surveillance Market Insights – Innovation and Specialty Leadership
The American Chemistry Council (ACC) projects steady annual demand growth for specialty and performance chemicals, particularly in automotive, electronics, agriculture, and construction applications. The US continues to lead in specialty and high-value-added chemicals, with investments focused on R&D, advanced process technologies, and digital manufacturing. In addition, the Canadian and Mexican markets offer lucrative growth pockets for manufacturers and vendors. Focus on private-brand offerings and promotions, diversified sales channels, expansion into niche segments, adoption of advanced technologies, and sustainability are widely observed across the North American Antimicrobial Resistance Surveillance Market.
Europe Antimicrobial Resistance Surveillance Market Outlook 2025 – Regulatory and Innovation-Driven Growth
Europe is one of the largest markets for Antimicrobial Resistance Surveillance Market with demand from both Western Europe and Eastern European regions increasing over the medium to long-term future. The European chemical sector employs more than 1.2 million people directly and is highly influenced by the EU Green Deal, which aims for climate neutrality by 2050. With increasing adoption of advanced technologies, raw materials, and digital transformation, Europe remains a strategic hub for Antimicrobial Resistance Surveillance Industry competitiveness. The report analyses the key Antimicrobial Resistance Surveillance Market drivers and opportunities across Germany, France, the United Kingdom, Spain, Italy, Russia, and other Europe.
Latin American Antimicrobial Resistance Surveillance Market outlook rebounds in line with economic growth
Optimistic economic outlook across Brazil, Argentina, Chile, and other South and Central American countries presents strong opportunities for domestic and international Antimicrobial Resistance Surveillance Market companies. Increased consumer spending is estimated across markets over the next few quarters through 2026. Expanding trade partnerships, urbanization, and growing demand for specialty products underpin market prospects.
Middle East and Africa Antimicrobial Resistance Surveillance Markets- New Opportunities for Companies Harnessing Diversity
The Middle East remains a key hub for Antimicrobial Resistance Surveillance Market companies, with Saudi Arabia, UAE, and Qatar investing heavily in distribution networks. In addition, Africa presents strong growth potential in Nigeria, South Africa, and other emerging economies, with increasing demand for cost effective and accessible products. Investment strategies tailored to localized needs and sustainable growth will be crucial for success. In addition to Nigeria, Algeria, South Africa, and other markets, steady growth markets in Ethiopia, Rwanda, Ghana, Tanzania, the Democratic Republic of Congo, and others present significant prospects for companies.
Competitive Landscape – How Antimicrobial Resistance Surveillance Market Companies Outcompete in 2025
The ability to adapt to changing regulations, sustainability imperatives, and customer-specific innovations defines leadership in the Antimicrobial Resistance Surveillance Market. Companies are leveraging M&A activities, strategic joint ventures, and vertical integration to secure raw material access and strengthen downstream presence. The report profiles leading players, analyzing their 2024 revenues, market shares, R&D expenditures, and strategic directions. The report analyzes Abbott Laboratories, Accelerate Diagnostics Inc, Alifax S.r.l., Becton, Dickinson and Company, Bioanalyse GmbH, bioMérieux SA, Bio-Rad Laboratories Inc, BioSpace Inc, Bruker Corp, Danaher Corp, Danaher Corp, F. Hoffmann-La Roche Ltd, Liofilchem S.r.l., Lumed LLC, Luminex Corp, Merck KGaA, OpGen Inc, QIAGEN N.V., Thermo Fisher Scientific Inc, Wolters Kluwer N.V.. Each company is benchmarked through a detailed SWOT and financial analysis, providing clients with insights into competitive positioning and innovation leadership.
Antimicrobial Resistance Surveillance Market Scope
Leading Segments
By Solution
Diagnostic kits
Diagnostic systems
Surveillance software
Services
By Application
Clinical Diagnostics
Public Health Surveillance
Others
By End-User
Hospitals & Clinics
Research & Academic Institutes
Others
Leading Companies
Abbott Laboratories
Accelerate Diagnostics Inc
Alifax S.r.l.
Becton, Dickinson and Company
Bioanalyse GmbH
bioMérieux SA
Bio-Rad Laboratories Inc
BioSpace Inc
Bruker Corp
Danaher Corp
Danaher Corp
F. Hoffmann-La Roche Ltd
Liofilchem S.r.l.
Lumed LLC
Luminex Corp
Merck KGaA
OpGen Inc
QIAGEN N.V.
Thermo Fisher Scientific Inc
Wolters Kluwer N.V.
Geographies
North America- US, Canada, Mexico
Europe- Germany, France, UK, Spain, Italy, Nordics, BeNeLux, Others
Asia Pacific- China, India, Japan, South Korea, Australia, South East Asia, Others
Latin America- Brazil, Argentina, Others
Middle East and Africa- Saudi Arabia, UAE, Other Middle East, South Africa, Other Africa
Reasons to Buy the Report
Table of Contents
193 Pages
- 1. Table of Contents
- List of Figures and Tables
- 2. Executive Summary
- 2.1 Key Highlights
- 2.1.1 Antimicrobial Resistance Surveillance Market Size Outlook, 2018-2024 and 2025-2032
- 2.1.2 Largest Antimicrobial Resistance Surveillance Market Types and Applications
- 2.1.3 Fastest Growing Segments
- 2.1.4 Potential Markets
- 2.1.5 Market Concentration
- 2.2 Market Scope and Segmentation
- 2.2.1 Market Scope- Segments
- 2.2.2 Market Scope- Countries
- 2.2.3 Macroeconomic and Demographic Outlook
- 2.2.4 Abbreviations
- 2.2.5 Units and Currency Conversions
- 3. Research Methodology
- 3.1 Primary Research Surveys
- 3.2 Secondary Data Sources
- 3.3 Data Triangulation
- 3.4 Forecast Methodology
- 3.5 Assumptions and Limitations
- 4. Introduction to Global Antimicrobial Resistance Surveillance Market in 2025
- 4.1 Industry Panorama
- 4.2 Leading Companies Profiled in the Study
- 4.3 Asia Pacific Markets offer Robust Market Prospects for New Entrants
- 4.4 Market Dynamics
- 4.4.1 Market Dynamics- Trends and Drivers
- 4.4.2 Market Dynamics- Opportunities and Challenges
- 4.5 Regional Analysis
- 4.6 Porter’s Five Force Analysis
- 4.6.1 Intensity of Competitive Rivalry
- 4.6.2 Threat of New Entrants
- 4.6.3 Threat of Substitutes
- 4.6.4 Bargaining Power of Buyers
- 4.6.5 Bargaining Power of Suppliers
- 4.7 Antimicrobial Resistance Surveillance Market Industry Value Chain Analysis
- 4.7.1 Stage of Value Chain
- 4.7.2 Key Activities of Companies
- 4.7.3 Companies Included in Each Stage
- 4.7.4 Key Insights
- 5. Antimicrobial Resistance Surveillance Market Outlook to 2032
- 5.1 Market Size Forecast by Type, 2021-2024 and 2025-2032
- 5.2 Market Size Forecast by Application, 2021-2024 and 2024-2032
- 5.3 Market Size Forecast by Geography, 2021-2024 and 2024-2032
- By Solution
- Diagnostic kits
- Diagnostic systems
- Surveillance software
- Services
- By Application
- Clinical Diagnostics
- Public Health Surveillance
- Others
- By End-User
- Hospitals & Clinics
- Research & Academic Institutes
- Others
- 6. Global Antimicrobial Resistance Surveillance Market Outlook across Growth Scenarios
- 6.1 Low Growth Scenario
- 6.2 Base/Reference Case
- 6.3 High Growth Scenario
- 6. North America Antimicrobial Resistance Surveillance Market Size Outlook
- 6.1 Key Market Statistics, 2024
- 6.2 North America Antimicrobial Resistance Surveillance Market Trends and Growth Opportunities
- 6.2.1 North America Antimicrobial Resistance Surveillance Market Outlook by Type
- 6.2.2 North America Antimicrobial Resistance Surveillance Market Outlook by Application
- 6.3 North America Antimicrobial Resistance Surveillance Market Outlook by Country
- 6.3.1 The US Antimicrobial Resistance Surveillance Market Outlook, 2021- 2032
- 6.3.2 Canada Antimicrobial Resistance Surveillance Market Outlook, 2021- 2032
- 6.3.3 Mexico Antimicrobial Resistance Surveillance Market Outlook, 2021- 2032
- 7. Europe Antimicrobial Resistance Surveillance Market Size Outlook
- 7.1 Key Market Statistics, 2024
- 7.2 Europe Antimicrobial Resistance Surveillance Market Trends and Growth Opportunities
- 7.2.1 Europe Antimicrobial Resistance Surveillance Market Outlook by Type
- 7.2.2 Europe Antimicrobial Resistance Surveillance Market Outlook by Application
- 7.3 Europe Antimicrobial Resistance Surveillance Market Outlook by Country
- 7.3.2 Germany Antimicrobial Resistance Surveillance Market Outlook, 2021- 2032
- 7.3.3 France Antimicrobial Resistance Surveillance Market Outlook, 2021- 2032
- 7.3.4 The UK Antimicrobial Resistance Surveillance Market Outlook, 2021- 2032
- 7.3.5 Spain Antimicrobial Resistance Surveillance Market Outlook, 2021- 2032
- 7.3.6 Italy Antimicrobial Resistance Surveillance Market Outlook, 2021- 2032
- 7.3.7 Russia Antimicrobial Resistance Surveillance Market Outlook, 2021- 2032
- 7.3.8 Rest of Europe Antimicrobial Resistance Surveillance Market Outlook, 2021- 2032
- 8. Asia Pacific Antimicrobial Resistance Surveillance Market Size Outlook
- 8.1 Key Market Statistics, 2024
- 8.2 Asia Pacific Antimicrobial Resistance Surveillance Market Trends and Growth Opportunities
- 8.2.1 Asia Pacific Antimicrobial Resistance Surveillance Market Outlook by Type
- 8.2.2 Asia Pacific Antimicrobial Resistance Surveillance Market Outlook by Application
- 8.3 Asia Pacific Antimicrobial Resistance Surveillance Market Outlook by Country
- 8.3.1 China Antimicrobial Resistance Surveillance Market Outlook, 2021- 2032
- 8.3.2 India Antimicrobial Resistance Surveillance Market Outlook, 2021- 2032
- 8.3.3 Japan Antimicrobial Resistance Surveillance Market Outlook, 2021- 2032
- 8.3.4 South Korea Antimicrobial Resistance Surveillance Market Outlook, 2021- 2032
- 8.3.5 Australia Antimicrobial Resistance Surveillance Market Outlook, 2021- 2032
- 8.3.6 South East Asia Antimicrobial Resistance Surveillance Market Outlook, 2021- 2032
- 8.3.7 Rest of Asia Pacific Antimicrobial Resistance Surveillance Market Outlook, 2021- 2032
- 9. South America Antimicrobial Resistance Surveillance Market Size Outlook
- 9.1 Key Market Statistics, 2024
- 9.2 South America Antimicrobial Resistance Surveillance Market Trends and Growth Opportunities
- 9.2.1 South America Antimicrobial Resistance Surveillance Market Outlook by Type
- 9.2.2 South America Antimicrobial Resistance Surveillance Market Outlook by Application
- 9.3 South America Antimicrobial Resistance Surveillance Market Outlook by Country
- 9.3.1 Brazil Antimicrobial Resistance Surveillance Market Outlook, 2021- 2032
- 9.3.2 Argentina Antimicrobial Resistance Surveillance Market Outlook, 2021- 2032
- 9.3.3 Rest of South and Central America Antimicrobial Resistance Surveillance Market Outlook, 2021- 2032
- 10. Middle East and Africa Antimicrobial Resistance Surveillance Market Size Outlook
- 10.1 Key Market Statistics, 2024
- 10.2 Middle East and Africa Antimicrobial Resistance Surveillance Market Trends and Growth Opportunities
- 10.2.1 Middle East and Africa Antimicrobial Resistance Surveillance Market Outlook by Type
- 10.2.2 Middle East and Africa Antimicrobial Resistance Surveillance Market Outlook by Application
- 10.3 Middle East and Africa Antimicrobial Resistance Surveillance Market Outlook by Country
- 10.3.1 Saudi Arabia Antimicrobial Resistance Surveillance Market Outlook, 2021- 2032
- 10.3.2 The UAE Antimicrobial Resistance Surveillance Market Outlook, 2021- 2032
- 10.3.3 Rest of Middle East Antimicrobial Resistance Surveillance Market Outlook, 2021- 2032
- 10.3.4 South Africa Antimicrobial Resistance Surveillance Market Outlook, 2021- 2032
- 10.3.5 Egypt Antimicrobial Resistance Surveillance Market Outlook, 2021- 2032
- 10.3.6 Rest of Africa Antimicrobial Resistance Surveillance Market Outlook, 2021- 2032
- 11. Company Profiles
- 11.1 Leading 10 Companies
- Abbott Laboratories
- Accelerate Diagnostics Inc
- Alifax S.r.l.
- Becton, Dickinson and Company
- Bioanalyse GmbH
- bioMérieux SA
- Bio-Rad Laboratories Inc
- BioSpace Inc
- Bruker Corp
- Danaher Corp
- Danaher Corp
- F. Hoffmann-La Roche Ltd
- Liofilchem S.r.l.
- Lumed LLC
- Luminex Corp
- Merck KGaA
- OpGen Inc
- QIAGEN N.V.
- Thermo Fisher Scientific Inc
- Wolters Kluwer N.V.
- 11.2 Overview
- 11.3 Products and Services
- 11.4 SWOT Profile
- 12. Appendix
- 12.1 Subscription Options
- 12.2 Customization Options
- 12.3 Publisher Details
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
